Cullinan Therapeutics Inc (CGEM)
Stock-Based Compensation
$32.84M
TTM · Period ending: · USD
CGEM Stock-Based Compensation
Latest reported$32.84Mperiod ending
Latest reported$32.84Mperiod ending
CGEM Stock-Based Comp ($0.00 → $32.84M)
Annual stock-based compensation
High-resolution chart · PNG
CGEM stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 36,040,000 | |
| 37,824,000 | |
| 30,438,000 | |
| 27,957,000 | |
| 24,375,000 | |
| 0 | |
| 0 | |
| 0 |